- Energy Thermogenic
- Boost Metabolism
- Appetite Support
- Thermogenic Energizer
- 60 Servings
- Dietary Supplement
Trans4orm Thermogenic Energizer When Combined With Regular Training, Trans4orm is Engineered To Support:
- Curbed Appetite
- Fat Burner
|Serving Size: 2 Capsules|
|Servings Per Container: 60|
|Amount Per Serving||%Daily Value|
|Niacin (Vitamin B3)||15 mg||75%|
|Vitamin B6 (Pyridoxine HCI)||2 mg||100%|
|Folic Acid||400 mcg||100%|
|Vitamin B12 (as Methylcobalamin)||6 mcg||100%|
|Green Tea Leaf Extract (std. min. 50% EGCG)||500 mg||*|
|Choline Bitartrate||200 mg||*|
|Caffeine Anhydrous||175 mg||*|
|Theacrine (as TeaCrine)||25 mg||*|
|Alpha-Glycerophosphorylcholine Powder (std. min. 50% A-GPC)||25 mg||*|
|Huperiza Serrata Extract
(std. min. 1% Huperzine A) (Club Moss)
|Black Pepper Extract (std. min. 98% piperine) (fruit)||1.25 mg||*|
|Rauwolfia Vomitoria Extract
(std. min 90% Rauwolscine) (root bar)
|Percent Daily Values are based on a 2,000 calorie diet.
†Daily Value not established.
Not intended for use by persons under 18. Do not exceed recommended dose. Do not consume caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phhenylephrine or caffeine. Contains caffeine. Do not use for more than 8 weeks. Consult with your physician prior to use if you are pregnant, nursing or taking medication, including but not limited to, MAO inhibitors, antidepressants, aspirin, nonsteroidal anti-inflammatory drugs or products containing phenylphrine, ephedrine, pseudoephedrine or other stimulants. Consult your physician prior to use if have have a medical condition, including but not limited to, heart, liver, kidney or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heartbeat, dizziness, severe headache or shortness of breath.
There are no reviews yet.